Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1α, 25‐dihydroxy‐22‐oxacalcitriol) in 17 patients
- 9 March 2007
- journal article
- Published by Wiley in The Journal of Dermatology
- Vol. 34 (4) , 264-266
- https://doi.org/10.1111/j.1346-8138.2007.00266.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Successful Treatment of Therapy‐Resistant Plantar Verrucae Vulgares with Systemic Interferon‐βThe Journal of Dermatology, 2004
- Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patientsBritish Journal of Dermatology, 2004
- PsoriasisThe Lancet, 2003
- Local treatments for cutaneous warts: systematic review * Commentary: Systematic reviewers face challenges from varied study designsBMJ, 2002
- Nonpsoriatic Uses of CalcipotriolJournal of Cutaneous Medicine and Surgery, 2002
- Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasisArchives of Dermatological Research, 2001
- Seizures associated with interferon-α treatment of cutaneous malignanciesBritish Journal of Dermatology, 1999
- Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparatorBritish Journal of Dermatology, 1999
- Efficacy, Tolerability, and Safety of Calcipotriol Ointment in Disorders of KeratinizationArchives of Dermatology, 1995
- Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative studyArchives of Dermatology, 1995